Joseph Sciasci
Areas of expertise: Pediatric oncology, Blood/Marrow Transplant
About Joseph Sciasci
Titles
Clinical Pharmacy Specialist
Leadership and Memberships
Memberships in professional organizations
Pediatric Pharmacy Advocacy Group (PPAG)
Children’s Oncology Group (COG)
American Society of Health-System Pharmacy (ASHP)
American College of Clinical Pharmacy (ACCP)
Research Interests
Implementation of pharmacogenetics into clinical practice
Discharge medication counseling
Education & training
Graduate Degree
PharmD - Philadelphia College of Pharmacy at the University of the Sciences, Philadelphia, PA
Residency
Pharmacy Practice (PGY 1) - Children’s Hospital of Wisconsin, Milwaukee, WI
Pharmacy Practice (PGY 2) - St. Jude Children’s Research Hospital, Memphis, TN
Publications
Publications
2018
Quinn M, Fannin JT, Sciasci J, Bragg A, Campbell PK, Carias D, Crews KR, Gregornik D, Jeha S, Maron G, Pauley JL, Swanson HD, Wolf J, Greene W. 2018. Pentamidine for prophylaxis against Pneumocystis jirovecii pneumonia in pediatric oncology patients receiving immunosuppressive chemotherapy. Antimicrob Agents Chemother 62:e00173-18.
Hill DA, Leahy AB, Sciasci JN, O’Neill SP, Reilly A, Balamuth N, Seeholzer SH, Spergel JM, Brown-Whitehorn TF. Medication contaminants as a potential cause of anaphylaxis to vincristine. J Pediatr Blood Cancer. 2018 Jan;65(1).
2017
Hill DA, Leahy AB, Sciasci J, et. al. Medication contaminants as a potential cause of anaphylaxis to vincristine. Pediatr Blood Cancer. 2017;00:e26761.
2016
Watts CS, Sciasci JN, Pauley JL, Panetta JC, PeiDE, Cheng CH, Christensen CM, Mikkelsen TS, Pui CH, Jeha SI, Relling MV. Prophylactic trimethoprim-sulfamethoxazole does not affect pharmacokinetics or pharmacodynamics of methotrexate. J Pediatr Hematol Oncol 2016 Aug;38(6):449-52.